Concepedia

Samnang Tep

ST

14

Publications

568

Citations

12

H-Index

2005

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Biogen (United States)

Northeastern University

Amgen (United States)

Eli Lilly (United States)

Samnang Tep is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and natural sciences.

Top concepts

Publications per year

2005–2024

14

Publications

14

Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 1: Separation-based methods

Dietmar Reusch, Markus Haberger, B.P.K. Maier et al. · mAbs · 2014 · 159 citations · Full text

, , +22

siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids

Marija Tadin‐Strapps, Laurence B. Peterson, Anne-Marie Cumiskey et al. · Journal of Lipid Research · 2011 · 73 citations · Full text

Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9

Brandon Ason, Samnang Tep, Jr. Harry R. Davis et al. · Journal of Lipid Research · 2011 · 49 citations · Full text

A comparison of three techniques for quantitative carbohydrate analysis used in characterization of therapeutic antibodies

Joseph Siemiatkoski, Yelena Lyubarskaya, Damian J. Houde et al. · Carbohydrate Research · 2005 · 48 citations

, , +16

Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation

Johan D. Oslob, Russell J. Johnson, Haiying Cai et al. · ACS Medicinal Chemistry Letters · 2012 · 43 citations · Full text

, , +17

Rows per page

1–5 of 14